Table 1.
Characteristic of included studies
| Article | Country | Cancer type | Number of subjects (n) | Study design (CC or CS) | Level synoptic reporting | Origin guidelines | ||
|---|---|---|---|---|---|---|---|---|
| Before | Step 1 | Step 2 | ||||||
| Appleton [23] | UK | Breast | 40 | CS | 1 | 2 | 3 | NHSBSP |
| Aumann [24] | Germany | Prostate | 1049 | CS | 1 | 3 | 5 | CAP |
| Aumann [25] | Germany | Lung | 878 | CS | 1 | 3 | 5 | CAP |
| Austin [19] | Australia | Breast | 402 | CS | 1 | 3 | – | ACN |
| Beattie [26] | Ireland | Colorectal | 171 | CC | 1 | 3 | – | RCP |
| Branston [28] | UK | Breast and colorectal | 2042 | CC | 1 | 4 | – | RCP |
| Buchwald [29] | Sweden | Colon | 302 | CC | 1 | 3 | – | Own |
| Casati [30] | Norway | Colorectal | 1221 | CC | 1 | 1 and 5 | – | RCP |
| Chan [18] | Canada | Colorectal | 407 | CS | 1 | 3 | 4 | CAP |
| Cross [31] | UK | Colorectal | 272 | CS | 1 | 2 | 3 | RCP |
| Gill [20] | Australia | Pancreatic | 177 | CC | 1 | 3 | – | CAP |
| Hammond [32] | USA | Breast | 796 | CS | 1 | 3 | – | Own |
| Hassel [33] | USA | Breast, prostate and melanoma | 368 | CC | 1 | 4 | – | CAP |
| Haugland [34] | Norway | Colorectal | 650 | CS | 1 | 5 | – | RCP |
| Haydu [35] | Australia | Melanoma | 3784 | CS | 1 | 3 | 1 and 3 | 2008 Melanoma Guidelines |
| Idowu [36] | USA | Breast, colorectal and prostate | 2125 | CS | 1 | 3 | – | CAP |
| Ihnat [37] | Czech Republic | Colorectal | 177 | CC | 1 | 3 | – | CAP |
| Kahn [38] | Australia | Thyroid | 448 | CS | 1 | 3 | – | RCPA |
| Karim [39] | Australia | Melanoma | 1692 | CC | 1 | 3 | – | Own |
| Mathers [40] | UK | Breast | 100 | CC | 1 | 3 | – | RCP |
| McEvoy [41] | Australia | Breast | 1649 | CS | ? | 3 | – | NHMRC |
| Messenger [42] | Canada | Rectal | 498 | CS | 1 | 3 | 6 | CAP |
| Porter, 2013 [43] | Canada | Rectal | 197 | CS | 1 | 3 | – | Own |
| Reid, 2000 [44] | UK | Uterine and cervix | 349 | CS | 1 | 3 | – | Own |
| Renshaw, 2014 [45] | USA | All synoptic pathology reports | 6193 | CS | 1 | 2 | 3 | CAP |
| Rigby, 2000 [46] | UK | Colorectal | 98 | CS | 1 | 3 | – | RCP |
| Siriwardana [21] | Sri Lanka | Colorectal | 168 | CS | 1 | 3 | – | RCP |
| Srigley [47] | Canada | Breast, lung, endometrium, colorectal, and prostate | 7594 | CS | 1 | 3 | 6 | CAP |
| Srigley [6] | Canada | Colorectal and prostate | All reports | CS | 1 | 3 | 6 | CAP |
| Ventura [48] | Italy | Prostate | 70 | CC | 1 | 3 | – | CAP |
| Westgaard [49] | Norway | Pancreatic | 506 | CS | 1 | 3 | – | Own |
| Westgaard [50] | Norway | Pancreatic | 218 | CS | 1 | 3 | – | Own |
| Woods [51] | UK | Colorectal | 953 | CS | 1 | 3 | – | RCP |
UK United Kingdom, USA United States of America, CC case-control, CS cross sectoral, NHSBSP National Health Service Breast Screening Programme, CAP College of American Pathologists, ACN Australian Cancer Network, RCP Royal College of Pathologists, RCPA Royal College of Pathologists Australasia, NHMRC National Health and Medical Research Council